SARS-CoV-2 seroprevalence and implications for population immunity: Evidence from two Health and Demographic Surveillance System sites in Kenya, February-June 2022

EW Kagucia, AK Ziraba, J Nyagwange, B Kutima, M Kimani, D Akech, M Ng’oda, A Sigilai, D Mugo, H Karanja, J Gitonga, A Karani, M Toroitich, B Karia, M Otiende, A Njeri, R Aman, P Amoth, M Mwangangi, K Kasera, W Ng’ang’a, S Voller, LI Ochola-Oyier, C Bottomley, A Nyaguara, PK Munywoki, G Bigogo, E Maitha, S Uyoga, KE Gallagher, AO Etyang, E Barasa, J Mwangangi, P Bejon, IMO Adetifa, GM Warimwe, JAG Scott, A Agweyu
doi: https://doi.org/10.1101/2022.10.10.22280824

Data Availability

All data produced in the present study are available upon reasonable request to the authors.

Back to top
Posted October 24, 2022.
Download PDF

Supplementary Material

Data/Code
Email
SARS-CoV-2 seroprevalence and implications for population immunity: Evidence from two Health and Demographic Surveillance System sites in Kenya, February-June 2022
EW Kagucia, AK Ziraba, J Nyagwange, B Kutima, M Kimani, D Akech, M Ng’oda, A Sigilai, D Mugo, H Karanja, J Gitonga, A Karani, M Toroitich, B Karia, M Otiende, A Njeri, R Aman, P Amoth, M Mwangangi, K Kasera, W Ng’ang’a, S Voller, LI Ochola-Oyier, C Bottomley, A Nyaguara, PK Munywoki, G Bigogo, E Maitha, S Uyoga, KE Gallagher, AO Etyang, E Barasa, J Mwangangi, P Bejon, IMO Adetifa, GM Warimwe, JAG Scott, A Agweyu
medRxiv 2022.10.10.22280824; doi: https://doi.org/10.1101/2022.10.10.22280824
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area